Dehua Wu

13PUBLICATIONS
36CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursCancer geneticsMolecular targetsCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Mar 13, 2026
Assessment of pneumonitis in patients with lung cancer undergoing radioimmunotherapy and immune checkpoint inhibitor rechallenge.

Yingchen Ruan, Minjie Ruan, Zhishen Fang

|Mar 05, 2026
CRTAM inhibition mitigates toxicity of immune checkpoint inhibitors without antitumor efficacy trade-off.

Si-Cong Ma, Zi-Xuan Rong, Zi-Peng Xu

|Dec 10, 2024
Spermine synthase engages in macrophages M2 polarization to sabotage antitumor immunity in hepatocellular carcinoma.

Yining Sun, Peitao Zhou, Junying Qian

|Oct 08, 2024
HLA diversity unveils susceptibility and organ-specific occurrence of second primary cancers: a prospective cohort study.

Zi-Xuan Rong, Wei Wei, Qin Zeng

|Jan 05, 2024
Two somatic mutations in the androgen receptor N-terminal domain are oncogenic drivers in hepatocellular carcinoma.

Qian-Nan Ren, Dan-Hui Huang, Xiao-Nan Zhang

|Mar 04, 2023
CDK4/6 inhibition triggers ICAM1-driven immune response and sensitizes LKB1 mutant lung cancer to immunotherapy.

Xue Bai, Ze-Qin Guo, Yan-Pei Zhang

Pageof 3

Frequent Collaborators

4 joint publications

Si-Cong Ma

4 joint publications

Li Liu

4 joint publications

Zhongyi Dong

3 joint publications

Yan-Pei Zhang